Investor Presentaiton
CET 1 WELL ABOVE MDA
CET 1 of 13.5% (1)
~420 bps over MDA (9.35%)
Solid balance sheet
Leverage ratio at 4.4%
TLAC ratio at 33.7%
Balance sheet meeting MREL
requirements
IFRS 9
phasing
~60% of 2023 funding programme
completed
_Q4 22 change in CET 1 (1) ratio (in bp)
+45bps
13.1%
+15 bps
-3bps
+1bps
13.5%
+17 bps
30.09.22(1)
Organic capital
generation (2)
OCI
Other
31.12.22 (1)
IFRS 9
phasing
2025 TARGET
12%
CET 1
under Basel IV
(1) Including IFRS 9 phasing, i.e. 13.3% fully loaded in Q4 22. Based on CRR2/CRD5 rules, including the Danish compromise for Insurance (see Methodology), (2) Based on the 2022 proposed distribution subject to usual approvals of the General meeting and the ECB
SOCIETE
GENERALE
4TH QUARTER AND FULL YEAR 2022 RESULTS 18 FEBRUARY 2023
14View entire presentation